Stockscreener 앱 받기
128.96
0.32%
0.41
시장 영업 전:
129.80
0.84
+0.65%
전일 마감가:
$128.55
열려 있는:
$125.66
하루 거래량:
9.89M
Relative Volume:
1.00
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+4.08%
1개월 성능:
+1.90%
6개월 성능:
+25.70%
1년 성능:
+60.02%
1일 변동 폭
$125.57
$129.95
1주일 범위
$118.28
$131.45
52주 변동 폭
$66.66
$132.09
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Compare XBI vs VTI, SPY, IVV, VB, QQQ
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
128.96 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
323.76 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
655.83 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
658.96 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
264.66 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
584.98 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf 주식(XBI)의 최신 뉴스
USA Stocks: Research Stocks from USA Stock Market - GuruFocus
This Biotech ETF Is Still Well Below Its 2021 Peak. Analysts Say That Is Exactly Why to Buy It. - Yahoo Finance
$1000 Invested In State Street SPDR S&P Biotech ETF 20 Years Ago Would Be Worth This Much Today - Sahm
iShares Biotechnology ETF (IBB) Stock Price, News, Quote & History - Yahoo! Finance Canada
First Trust NYSE Arca Biotechnology Index Fund (FBT) stock price, news, quote and history - sg.finance.yahoo.com
VanEck Biotech ETF (BBH) stock price, news, quote and history - sg.finance.yahoo.com
Direxion Daily S&P Biotech Bull 3X Shares (LABU) Stock Price, News, Quote & History - Yahoo! Finance Canada
Biotech Stocks Are Up About 35% in the Past Year and Analysts Say the Biggest Gains Are Still Ahead - 24/7 Wall St.
Trade State Street SPDR S&P Biotech ETFXBI CFD - Capital.com
Atika Capital Management LLC's State Street SPDR S&P Biotech ETF(XBI) Holding History - GuruFocus
Stock List: Research Stocks from Around the World - GuruFocus
ETFs Investing in Novavax, Inc. Stocks - TradingView
ETFs Investing in Moderna, Inc. Stocks - TradingView
ADMA Jumps 15% in Late-Day Rally: Biotech Market Turbulence Escalates Amid Options Trading Momentum - Bitget
Tango Therapeutics Ignites: 11% Surge to Historic Highs Signals Biotech Power Play - Bitget
US defense giant taps Israeli drone navigation tech built for jammed battlefields - The Jerusalem Post
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Scholar Rock Holding Surges 10.6% in Intraday Trade – What’s Behind the Volatility? - Bitget
Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. - The Motley Fool
Sector alert: 4 healthcare ETFs poised for explosive growth now - MSN
Biotech ETF with a twist: Defiance to donate initial advisory profits to autism causes - MSN
Autocall Notes Linked to Nasdaq-100 & ETFs (AMJB) — $3M Offering - Stock Titan
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM - sharewise.com
Beyond the Technology Sector: Discover How Biotech ETFs Are Leveraging the AI Boom - Bitget
Beyond Tech Industry: Here's how Biotech ETFs Are Riding the AI Wave - TradingView
XBI: Biotech M&A Has Been Hot, But Price Trends Have Cooled - Seeking Alpha
Biotech ETF With A Twist: Defiance To Donate Initial Advisory Profits To Autism Causes - Benzinga
BridgeBio Pharma Eyes First Treatment For Rare Muscle Disorder As Trial Data Shows Early Progress - Benzinga
Is Investing in the VanEck Biotech ETF (BBH) a Good Choice? - Bitget
AI Investing InsightsOfficial HomepageIntellectia AI™ - Intellectia AI
JPMorgan (AMJB) prices callable contingent‑interest notes linked to SCZ/XBI/KRE - Stock Titan
State Street SPDR S&P Biotech ETF Experiences Big Outflow - Nasdaq
How to Invest in SPDR S&P Biotech ETF (XBI) - The Motley Fool
This 1 ETF Keeps Outperforming the S&P 500- Expect it to Win Again This Year - AOL.com
Should You Invest in the State Street SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
The State Street SPDR Dow Jones REIT ETF Could Soar If These 2 Things Go Right - AOL.com
FDA Makes U-Turn Again On Moderna New Flu Vaccine Review, Stock Soars - Benzinga
A Golden Age of Biotech Is Upon Us, Thanks to AI. This ETF Offers 40% Upside. - Barron's
PTC Therapeutics Pulls Translarna Bid After FDA Flags Weak ProofPTC Therapeutics (NASDAQ:PTCT) - Benzinga
Do Wall Street Analysts Like Incyte Corporation Stock? - inkl
Do financial experts on Wall Street have a favorable opinion of Incyte Corporation shares? - Bitget
Sector Alert: 4 Healthcare ETFs Poised for Explosive Growth Now - The Motley Fool
Moderna, Mexico Partner To Boost Local Vaccine ProductionModerna (NASDAQ:MRNA) - Benzinga
Investors Are Flocking to This ETF. It Could Outperform the S&P 500 for Years. - AOL.com
4,441 Shares in SPDR S&P Telecom ETF $XTL Purchased by Arkadios Wealth Advisors - Defense World
These Three Biotechs Have the Right Mix as the Industry Gains - TheStreet Pro
Vaxcyte Pushes Next-Gen Pneumococcal Vaccine Into Phase 3 Phase - Benzinga
Biotech ETF (XBI) Hits New 52-Week High - TradingView
Where To Invest $100,000: Japan Stocks, AI, Baseball Cards - Bloomberg
Stock Market Today: Dow gains 250 points, S&P 500 and Nasdaq advance after Trump’s Greenland pivot boosts risk appetite - MarketWatch
Moderna Stock Explodes To New 52-Week High: What's Driving The Action? - Benzinga
State Street Spdr S P Biotech Etf (XBI) 재무 분석
State Street Spdr S P Biotech Etf (XBI)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.16%
0.62%
자본화:
|
볼륨(24시간):